Dettagli del prodotto
Luogo di origine: Cina
Marca: Hongbaiyi
Certificazione: COA, HPLC MR
Numero di modello: Hby-cardiogen
Documento: Brochure del prodotto PDF
Termini di trasporto & di pagamento
Quantità di ordine minimo: 5 kit
Prezzo: Negoziabile
Imballaggi particolari: 20mg o secondo le esigenze del cliente.
Tempi di consegna: 3-5 lavoro giorni dopo il vostro pagamento
Termini di pagamento: Alibaba, T/T, Western Union
Capacità di alimentazione: 20.000 scatole /month
Articolo: |
Cardiogeno 20mg |
Formula molecolare: |
C18H31N7O9 |
Volume: |
3 ml |
Peso molecolare: |
489,5 |
Sinonimi: |
SCHEMBL3194515 |
Condizioni di stoccaggio: |
-20 ° C. |
Purezza: |
98% |
Modulo: |
Solido liofilizzato |
Articolo: |
Cardiogeno 20mg |
Formula molecolare: |
C18H31N7O9 |
Volume: |
3 ml |
Peso molecolare: |
489,5 |
Sinonimi: |
SCHEMBL3194515 |
Condizioni di stoccaggio: |
-20 ° C. |
Purezza: |
98% |
Modulo: |
Solido liofilizzato |
Buy Bioregulator Peptide 99% Pure Bioregulator Cardiogen Peptide 20mg
Peptide Specifications
| SPECIFICATION | DESCRIPTION |
|---|---|
| Sequence | H-Ala-Glu-Asp-Arg-OH |
| Molecular Formula | C18H31N7O9 |
| Molecular Weight | 489.5 |
| CAS Number | Not reliably established |
| Vial Size | 3ml |
| Synonyms | SCHEMBL3194515 |
| Purity | ≥98.5% (HPLC) |
| Solubility | Soluble in water and BAC water |
| Storage Conditions | Store at -20°C to -4°C, sealed, away from heat and moisture |
| Physical Appearance | White lyophilized powder |
| Shelf Life | 36 months from date of manufacture when stored properly |
| Quality Verification | COA |
| Manufacturing Standard | / |
| Intended Application | For research only |
Cardiogen (20mg Bioregulator Peptide)
Cardiogen is a bioregulatory peptide recognized for its powerful effects on cardiac health and its systemic benefits, which include potential properties against certain cancers, notably sarcomas.
Initial research has concentrated on its application in severe heart conditions, such as myocardial infarction (heart attacks), hypertension, and chronic heart failure.
Detailed Overview and Research Insights
1. Cardiovascular Benefits
Cardiogen exerts a profound effect on the heart by modulating fibroblast activity, a process vital for tissue repair and scar formation. Its primary benefit is its ability to promote the proliferation of heart muscle cells (cardiomyocytes) while inhibiting the excessive growth of fibroblasts. This dual action helps maintain optimal cardiac remodeling after injury, leading to reduced scar tissue formation and ultimately helping to prevent the progression of heart failure.
2. Anticancer Potential
Intriguingly, Cardiogen displays a selective, dual-action mechanism. In healthy cardiac cells, it reduces programmed cell death (apoptosis) by down-regulating the p53 protein. Conversely, in particular cancer models—specifically sarcomas—Cardiogen dramatically enhances apoptosis (cell death). This suggests that the peptide can selectively target tumor cells, potentially based on their unique vascular characteristics, offering a novel and synergistic avenue for cancer treatment alongside standard therapies.
3. Prostate Health
In the context of the prostate, Cardiogen's regulatory effect on fibroblast signaling factors is key. These factors are known to create a microenvironment that facilitates the development and progression of prostate cancer. By normalizing these signaling factors, Cardiogen may offer potential benefits for both the prevention and clinical management of prostate-related malignancies.
Product Images
FAQ
Q1: Can I get some samples?
A: Yes, we can provide samples. However, customers must bear the shipping cost.
Q2: How to pay?
A: We accept various payment methods, including T/T and other options.
Q 3: What is your MOQ (Minimum Order Quantity)?
A: Our standard MOQ is 5kits. However, smaller quantities, such as 100 grams, can be arranged for a corresponding sample fee.
Q 4: What is the shipping time?
A: Orders are usually shipped within 3-7 days with a tracking number. Delivery times vary by destination. Please get in touch with us for details.
